Institutions / Deerfield Management Company, L.P. / Activity
Activity — Deerfield Management Company, L.P.
112 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Add | PHGE BiomX Inc. Common Stock | $8 | +2 +<0.01% | 131,272 <0.01% of portfolio | low |
| Q1 2026 as of | Exit | 124155110 Common stock | $-12.9K | -733K -100.00% | 0 | low |
| Q1 2026 as of | Exit | 67080N119 Common stock | $-55.0K | -167K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Abeona Therapeutics Inc. Common stock | $-210.8K | -40K -100.00% | 0 | low |
| Q1 2026 as of | Exit | National Vision Holdings, Inc. Common stock | $-265.5K | -10K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Intuitive Surgical Inc Common stock | $-273.6K | -483 -100.00% | 0 | low |
| Q1 2026 as of | New | Veradermics, Inc Common stock | $315.8K | +5K | 5,000 <0.01% of portfolio | low |
| Q1 2026 as of | Exit | BellRing Brands Inc Common stock | $-320.7K | -12K -100.00% | 0 | low |
| Q1 2026 as of | Exit | STERIS plc Common stock | $-342.8K | -1K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Repligen Corp Common stock | $-360.3K | -2K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Amphastar Pharmaceuticals, Inc. Common stock | $-397.7K | -15K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Healthcare Services Group Inc Common stock | $-406.5K | -21K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Xeris Biopharma Holdings, Inc. Common stock | $-410.0K | -52K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Harrow, Inc. Common stock | $-426.0K | -9K -100.00% | 0 | low |
| Q1 2026 as of | Exit | AbbVie Inc. Common stock | $-460.2K | -2K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Integra Lifesciences Holdings Corp Common stock | $-487.0K | -39K -100.00% | 0 | low |
| Q1 2026 as of | Exit | RxSight, Inc. Common stock | $-544.5K | -52K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Tandem Diabetes Care Inc Common stock | $-573.5K | -26K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Schrodinger, Inc. Common stock | $-607.7K | -34K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Cooper Companies, Inc. Common stock | $-638.1K | -8K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Zoetis Inc. Common stock | $-716.9K | -6K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Arvinas, Inc. Common stock | $-807.2K | -68K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Azenta Inc Common stock | $-859.3K | -26K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Revvity, Inc. Common stock | $-998.8K | -10K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Integer Holdings Corp Common stock | $-1.05M | -13K -100.00% | 0 | low |
| Q1 2026 as of | Exit | MDXG Mimedx Group, Inc. Common Stock | $-1.09M | -160K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Kenvue Inc. Common stock | $-1.13M | -65K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Ufp Technologies Inc Common stock | $-1.13M | -5K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Staar Surgical Co Common stock | $-1.20M | -52K -100.00% | 0 | low |
| Q1 2026 as of | Exit | ATEC Alphatec Holdings, Inc. Common Stock | $-1.21M | -57K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Stryker Corp Common stock | $-1.25M | -4K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Maximus Inc Common stock | $-1.43M | -17K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Abbott Laboratories Common stock | $-1.43M | -11K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Healthequity, Inc. Common stock | $-1.49M | -16K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Varex Imaging Corp Common stock | $-1.53M | -132K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Encompass Health Corp Common stock | $-1.62M | -15K -100.00% | 0 | low |
| Q1 2026 as of | Exit | National HealthCare Corp Common stock | $-1.66M | -12K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Merit Medical Systems Inc Common stock | $-1.66M | -19K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Addus HomeCare Corp Common stock | $-1.70M | -16K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Align Technology, Inc. Common stock | $-1.72M | -11K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Surgery Partners, Inc. Common stock | $-1.74M | -113K -100.00% | 0 | low |
| Q1 2026 as of | Trim | Envista Holdings Corp Common stock | $-1.79M | -70K -3.09% | 2,210,100 0.84% of portfolio | low |
| Q1 2026 as of | Exit | GoodRx Holdings, Inc. Common stock | $-1.79M | -660K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Cardinal Health Inc Common stock | $-1.85M | -9K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Corvel Corp Common stock | $-1.87M | -28K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Avanos Medical, Inc. Common stock | $-1.88M | -167K -100.00% | 0 | low |
| Q1 2026 as of | Trim | Embecta Corp. Common stock | $-1.92M | -217K -7.89% | 2,534,961 0.33% of portfolio | low |
| Q1 2026 as of | Exit | AtriCure Inc Common stock | $-2.06M | -52K -100.00% | 0 | low |
| Q1 2026 as of | Exit | 10x Genomics, Inc. Common stock | $-2.06M | -127K -100.00% | 0 | low |
| Q1 2026 as of | Exit | LeMaitre Vascular, Inc. Common stock | $-2.09M | -26K -100.00% | 0 | low |